Abstract
In our region, more than half the patients with osteoporosis are investigated and treated by general practitioners. We carried out two surveys to discover whether the diagnosis and treatment of osteoporosis were correctly carried out by general practitioners in the Midi-Pyrénées region. The first survey concerned 85 patients who had been diagnosed with osteoporosis by their general practitioner. These patients were being seen for the first time in a hospital or private practice setting by a rheumatologist who completed a questionnaire based solely on the history taken from the patient and the records in the patient's possession. For the second survey, 200 general practitioners who had referred patients to the rheumatology department were sent a questionnaire on their management of osteoporosis. Fifty-two physicians completed and returned the questionnaire. More than half the general practitioners started treatment of osteoporosis without fractures on the basis of standard spinal X-rays where the radiologist suggested bone mineral loss. The initial biological investigation was correctly carried out by only 6% of physicians. Treatment was correctly prescribed in only 34% of cases of osteoporosis with fractures, 50% of osteoporosis without fractures and 50% of senile cortical osteoporosis.
Similar content being viewed by others
References
Melton LJ, Chrischilles EA, Cooper C, Lane AW, Riggs BL. How many women have osteoporosis? J Bone Mineral Res 1992; 7:1005–10.
Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646–50.
Laroche M. Examen et surveillance d'une patiente présentant une ostéoporose. Tempo Médical 1993;483:19–20.
Laroche M. Reconnaitre et traiter un tassement vertébral vu en ville. Tempo Médical 1993;483:21–3.
Roux C. Tassement vertébral. La Revue du Praticien, 1995; 9:1115–9.
Marcelli C. Les ostéoporoses secondaires. La Revue du Praticien 1995;9:1125–32.
Rapport du comité scientifique du, GRIO. Intérêt et indications cliniques des mesures de masse osseuse par absorptiométrie biphotonique à rayons x. Rev Rhum 1994;7–8 (special issue).
Nagant de Deuxchaines C. L'ostéoporose d'involution. Impact Médecin 1990;54:33–5.
Alexadre, C. Traitement de l'ostéoporose. Tempo Médical 1993;3:1–4.
Sebert JL, Glowinski J, Marcelli C, Acquaviva P. Ostéoporose aui quotidien. Le Quotidien du médecin 1992;5019:1–13.
Ribot C, Trémollieres F, Pouillès JM. Traitement hormonal et prévention précoce et tardive de l'ostéoporose. Press Med 1995;24:999–1002.
Marx CW, Dailey GE, Cheney C. Do oestrogens improve bone mineral density in osteoporotic women over age 65. J Bone Mineral Res 1992;7:1275–9.
Lufkin EG, Whaner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with trans-dermal oestrogens. Ann Intern Med 1992;117:1–9.
Reginster JY. Calcitonin for prevention and treatment of osteoporosis. Am J Med 1993;95:45–8.
Rico H, Hernadez HR, Revilla M, Gomez-Castresara F. Salmon calcitonin reduces vertebral fracture rate in post-menopausal crush fracture syndrome. Bone Miner 1992;16:131–8.
Ribot C, Pouillès JM, Trémollieres F. A propos de la définition densitométrique de l'ostéoporose. Rev Rhum 1995;9:579–81.
Alexandre C. L'ostéoporose en question. Rev Rhum 1993; 60:407–1.
Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with post menopausal osteoporosis. N Engl J Med 1990;332:1265–71.
Watts NB, Harris ST, Genant HK et al. Intermittent cyclical etidronate treatment of post menopausal osteoporosis. N Engl J Med 1990;323:73–9.
Mamelle N, Meunier PJ, Dusan R, et al. Risk benefit ratio of sodium fluoride treatment in primary osteoporosis. Lancet 1988;ii:356–65.
Riggs BL, Hodgson SF, O'Fallon WM, et al. Effects of fluoride treatment on the fracture rate in post menopausal women with osteoporosis. N Engl J Med 1990;322:802–9.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Laroche, M., Mazières, B. & Groupe Rhumatologique d'Etudes Cliniques de Midi-Pyrénées. Does the french general practitioner correctly investigate and treat osteoporosis?. Clin Rheumatol 17, 139–143 (1998). https://doi.org/10.1007/BF01452261
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01452261